COVID-19 and male fertility: Understanding the impact
Researchers from Hvidovre Hospital in Denmark have in collaboration with Cryos investigated the impact of COVID-19 on male fertility.
The COVID-19 pandemic has raised many questions about whether the virus can be present in the semen of infected men, similar to what has been observed with other viruses like Ebola and Zika. This study aimed to explore if COVID-19 affects the quality of semen in men who have recovered from the virus. Previous research on this topic had limited statistical power, so this study sought to provide more robust insights.
Understanding the study
The study focused on the potential effects of the SARS-CoV-2 virus, responsible for COVID-19, on the male reproductive system. The virus uses a protein called angiotensin-converting enzyme (ACE2), which is found in testicular tissue, to enter cells. While some studies have looked at how severe COVID-19 affects testicular function, few have explored the long-term effects of mild COVID cases. Additionally, this study examined a hormone called insulin-like factor 3 (INSL3), which had not been assessed during the early stages of SARS-CoV-2 infection.
The research process
Researchers examined 43 men between the ages of 30 and 64 who were recovering from mild COVID-19. They collected various biological samples, including saliva, urine before and after ejaculation, and semen, to directly check for the presence of the SARS-CoV-2 virus. They also measured inflammatory markers (e.g. Interleukin 8 (IL-8)) and assessed semen quality. Participants answered questionnaires to provide information about their urological, sexual, and reproductive history.
Key findings
During the acute phase of SARS-CoV-2 infection, participants had lower levels of testosterone and higher levels of luteinizing hormone, which are hormones related to reproduction, compared to three and six months later. This indicated a temporary impact on testicular function. The levels of INSL3 were also lower during the acute phase compared to three months later. Furthermore, the number of motile sperm cells was lower during the acute phase compared to six months later. This reduction in motile sperm cells was linked to older age and hospitalization during the COVID-19 infection. Some participants had fewer than 100,000 motile sperm cells, a condition known as oligo-crypto-azoospermia, which was associated with inflammation indicated by elevated levels of IL-8.
Conclusion
This study sheds light on the impact of COVID-19 on male fertility. It found temporary impacts in testicular function during the acute phase of the infection, and decreased number of motile sperms in some individuals. However, no SARS-CoV-2 was detected in semen at any time point. Febrile episodes during the infection may affect testicular function, but a direct effect of the virus on fertility cannot be ruled out. Further research is needed to fully understand the relationship between COVID-19 and male fertility.
If you are interested in seeing more studies about the impact of COVID-19, we can recommend Sperm depositors during a global pandemic and or A cohort study of men infected with COVID-19 for presence of SARS-CoV-2 virus in their semen.
